Boston Scientific Corp. (BSX)
48.10
-0.20
(-0.41%)
USD |
NYSE |
Sep 01, 16:00
48.03
-0.07
(-0.15%)
After-Hours: 16:15
Boston Scientific Research and Development Expense (Annual) : 2.052B for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 2.052B |
| December 31, 2024 | 1.615B |
| December 31, 2023 | 1.414B |
| December 31, 2022 | 1.323B |
| December 31, 2021 | 1.204B |
| December 31, 2020 | 1.143B |
| December 31, 2019 | 1.174B |
| December 31, 2018 | 1.113B |
| December 31, 2017 | 997.00M |
| December 31, 2016 | 920.00M |
| December 31, 2015 | 876.00M |
| December 31, 2014 | 817.00M |
| December 31, 2013 | 861.00M |
| December 31, 2012 | 886.00M |
| December 31, 2011 | 895.00M |
| December 31, 2010 | 939.00M |
| December 31, 2009 | 1.032B |
| Date | Value |
|---|---|
| December 31, 2008 | 999.00M |
| December 31, 2007 | 1.089B |
| December 31, 2006 | 1.008B |
| December 31, 2005 | 680.00M |
| December 31, 2004 | 569.00M |
| December 31, 2003 | 452.00M |
| December 31, 2002 | 343.00M |
| December 31, 2001 | 275.00M |
| December 31, 2000 | 199.00M |
| December 31, 1999 | 197.00M |
| December 31, 1998 | 200.28M |
| December 31, 1997 | 167.19M |
| December 31, 1996 | 116.30M |
| December 31, 1995 | 87.33M |
| December 31, 1994 | 29.54M |
| December 31, 1993 | 24.10M |
| December 31, 1992 | 16.89M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Abbott Laboratories | 2.889B |
| Becton, Dickinson & Co. | 1.265B |
| Penumbra, Inc. | 69.43M |
| Intuitive Surgical, Inc. | 1.312B |
| Stryker Corp. | 1.567B |